DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
48 hedge funds and large institutions have $2.16M invested in DMK Pharmaceuticals Corporation Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less capital invested
Capital invested by funds: $2.55M → $2.16M (-$395K)
Holders
48
Holding in Top 10
–
Calls
$142K
Puts
$5K
Top Buyers
| 1 | +$16.4K | |
| 2 | +$15.1K | |
| 3 | +$12.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.96K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$6.9K |
Top Sellers
| 1 | -$29.3K | |
| 2 | -$29K | |
| 3 | -$12.9K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$12K |
| 5 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
-$4K |